/TSNLF
TSNLF Stock - Tristel PLC
Healthcare|Medical - Instruments & SuppliesOTC
$5.14+0.00%
+$0.00 (+0.00%) • Dec 19
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.43
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $5.65
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for TSNLF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$5.09 – $5.19
TARGET (TP)$5.91
STOP LOSS$4.73
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.23
52W High$5.29
52W Low$5.08
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $46.46M | $41.93M | $36.01M | $31.00M | $31.68M |
| Gross Profit | $37.94M | $33.58M | $29.18M | $24.74M | $25.25M |
| Gross Margin | 81.7% | 80.1% | 81.0% | 79.8% | 79.7% |
| Operating Income | $8.40M | $6.98M | $5.28M | $4.76M | $6.80M |
| Net Income | $6.64M | $6.49M | $4.46M | $3.66M | $5.10M |
| Net Margin | 14.3% | 15.5% | 12.4% | 11.8% | 16.1% |
| EPS | $0.14 | $0.14 | $0.09 | $0.08 | $0.11 |
Company Overview
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand. Tristel plc was founded in 1993 and is headquartered in Snailwell, the United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
TSNLFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.07
Q1 2025
EPS Surprise History
Q2 21
No data
Q4 21
No data
Q2 22
No data
Q4 22
No data
Q2 23
No data
Q1 24
No data
Q4 24
No data
Q1 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 23, 2026 | — | — | — | — |
Q1 2025 | Feb 24, 2025 | — | $0.07 | — | — |
Q4 2024 | Oct 21, 2024 | — | $0.09 | — | — |
Q1 2024 | Feb 26, 2024 | — | $0.08 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.08 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.04 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.01 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.03 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.01 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.07 | — | — |
Q2 2020 | Jun 30, 2020 | — | $0.07 | — | — |
Q4 2019 | Dec 31, 2019 | — | $0.07 | — | — |
Q2 2019 | Jun 30, 2019 | — | $0.06 | — | — |
Q4 2018 | Dec 31, 2018 | — | $0.05 | — | — |
Q2 2018 | Jun 30, 2018 | — | $0.05 | — | — |
Q4 2017 | Dec 31, 2017 | — | $0.05 | — | — |
Q2 2017 | Jun 30, 2017 | — | $0.06 | — | — |
Q4 2016 | Dec 31, 2016 | — | $0.04 | — | — |
Q2 2016 | Jun 30, 2016 | — | $0.06 | — | — |
Q4 2015 | Dec 31, 2015 | — | $0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about TSNLF
What is TSNLF's current stock price?
Tristel PLC (TSNLF) is currently trading at $5.14 per share. The stock has moved +0.00% today.
What is the analyst price target for TSNLF?
No analyst price targets are currently available for this stock.
What sector is Tristel PLC in?
Tristel PLC operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the OTC exchange.
What is TSNLF's market cap?
Tristel PLC has a market capitalization of $0.25 billion, making it a small-cap company.
Does TSNLF pay dividends?
No, Tristel PLC does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAONC
American Oncology Network, Inc.
$5.80
Mkt Cap: $0.2B
BHCCF
Benchmark Holdings plc
$0.37
Mkt Cap: $0.2B
BRSYF
BrainsWay Ltd.
$8.73
Mkt Cap: $0.3B
CPHRF
Cipher Pharmaceuticals Inc.
$10.60
Mkt Cap: $0.3B
EVGRF
China Evergrande New Energy Vehicle Group Limited
$0.00
Mkt Cap: $0.0B
MAYNF
Mayne Pharma Group Limited
$2.36
Mkt Cap: $0.2B
MCDA
KMA Holding, Inc.
$0.00
Mkt Cap: $0.0B
OPORF
hVIVO plc
$0.24
Mkt Cap: $0.2B
ORPEF
Orpea S.A.
$14.22
Mkt Cap: $2.3B
SLNCF
Silence Therapeutics plc
$2.03
Mkt Cap: $0.3B
Explore stocks similar to TSNLF for comparison